Erlotinib protects against LPS-induced Endotoxicity because TLR4 needs EGFR to signal

Lipopolysaccharide (LPS)-Induced Biliary Epithelial Cell NRas Activation Requires Epidermal Growth Factor Receptor (EGFR)

(2015) Christy E. Trussoni et al.   PLoS One

EGF receptor uses SOS1 to drive constitutive activation of NF B in cancer cells

(2014) S. De et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells

(2013) Parnetta Sutton et al.   Molecular Cancer

Hepatocyte Growth Factor Inhibits Lipopolysaccharide-Induced Oxidative Stress via Epithelial Growth Factor Receptor Degradation

(2012) Kazutaka Shimizu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation

(2012) Katja Hattar et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Lyn kinase controls TLR4-dependent IKK and MAPK activation modulating the activity of TRAF-6/TAK-1 protein complex in mast cells

(2012) Martin Avila et al.   Innate Immunity

Transactivation of EGFR by LPS Induces COX-2 Expression in Enterocytes

(2012) Steven J. McElroy et al.   PLoS One

Epidermal Growth Factor Receptor Is Essential for Toll-Like Receptor 3 Signaling

(2012) M. Yamashita et al.   Science Signaling

Loss of CFTR Affects Biliary Epithelium Innate Immunity and Causes TLR4–NF-κB—Mediated Inflammatory Response in Mice

(2011) Romina Fiorotto et al.   GASTROENTEROLOGY

Human beta-defensin-3 (hBD-3) upregulated by LPS via epidermal growth factor receptor (EGFR) signaling pathways to enhance lymphatic invasion of oral squamous cell carcinoma

(2011) Yu Shuyi et al.   ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS

Toll-like receptor 4 differentially regulates epidermal growth factor-related growth factors in response to intestinal mucosal injury

(2010) David Hsu et al.   LABORATORY INVESTIGATION

Epidermal growth factor receptor in relation to tumor development: EGFR-targeted anticancer therapy

(2009) Isamu Okamoto   FEBS Journal

Animal models of sepsis and sepsis-induced kidney injury

(2009) Kent Doi et al.   JOURNAL OF CLINICAL INVESTIGATION

Lipopolysaccharide Initiates a Positive Feedback of Epidermal Growth Factor Receptor Signaling by Prostaglandin E2 in Human Biliary Carcinoma Cells

(2009) L. Finzi et al.   JOURNAL OF IMMUNOLOGY

The NF- B Family of Transcription Factors and Its Regulation

(2009) A. Oeckinghaus et al.   Cold Spring Harbor Perspectives in Biology

Multiple TLRs activate EGFR via a signaling cascade to produce innate immune responses in airway epithelium

(2008) Jonathan L. Koff et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Shared Principles in NF-κB Signaling

(2008) Matthew S. Hayden et al.   CELL

LPS/TLR4 signal transduction pathway

(2008) Yong-Chen Lu et al.   CYTOKINE

‘Yin and Yang’ in inflammation: duality in innate immune cell function and tumorigenesis

(2008) Mahin Khatami   EXPERT OPINION ON BIOLOGICAL THERAPY

NF-κB in carcinoma therapy and prevention

(2008) Matthew Brown et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Helicobacter pyloriProtein HP0175 Transactivates Epidermal Growth Factor Receptor through TLR4 in Gastric Epithelial Cells

(2008) Sanchita Basu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network

(2008) Sandra Morandell et al.   PROTEOMICS

Src family kinases: Regulation of their activities, levels and identification of new pathways

(2007) Evan Ingley   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Dendritic cells and cytokines in immune rejection of cancer

(2007) M FERRANTINI et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Lipopolysaccharide induces VCAM-1 expression and neutrophil adhesion to human tracheal smooth muscle cells: Involvement of Src/EGFR/PI3-K/Akt pathway

(2007) W LIN et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY